Cyclo Therapeutics PE Ratio Analysis

Cyclo Therapeutics Inc (CYTH)

0.715 +0.02 (+2.29%) USD | NASDAQ | Nov 22, 10:20

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2002. Upgrade now.

Date	Value
June 27, 2014	130.56
June 26, 2014	127.90
June 25, 2014	123.22
June 24, 2014	126.30
June 23, 2014	127.90
June 20, 2014	137.23
June 19, 2014	131.90
June 18, 2014	125.90
June 17, 2014	115.78
June 16, 2014	112.58
June 13, 2014	111.91
June 12, 2014	105.25
June 11, 2014	103.92
June 10, 2014	105.25
June 09, 2014	109.23
June 06, 2014	99.92
June 05, 2014	90.60
June 04, 2014	93.26
June 03, 2014	94.59
June 02, 2014	94.59
May 30, 2014	91.93
May 29, 2014	95.25
May 28, 2014	86.60
May 27, 2014	83.93
May 23, 2014	95.26

Date	Value
May 22, 2014	78.60
May 21, 2014	73.28
May 20, 2014	89.26
May 19, 2014	89.26
May 16, 2014	90.60
May 15, 2014	89.26
May 14, 2014	93.26
May 13, 2014	92.62
May 12, 2014	89.26
May 09, 2014	82.60
May 08, 2014	83.27
May 07, 2014	78.60
May 06, 2014	71.93
May 05, 2014	69.28
May 02, 2014	79.92
May 01, 2014	89.26
April 30, 2014	87.93
April 29, 2014	89.26
April 28, 2014	85.27
April 25, 2014	79.94
April 24, 2014	71.94
April 23, 2014	66.61
April 22, 2014	69.28
April 21, 2014	66.61
April 17, 2014	65.95

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

PE Ratio Benchmarks

Stryker Corp	41.33
Biogen Inc	14.28
Pfizer Inc	34.58
Pacira BioSciences Inc	--
Moderna Inc	--

PE Ratio Related Metrics

PS Ratio	22.19
Price	0.715
Earnings Yield	-125.9%
Market Cap	20.57M